BlackRock
OM icon

BlackRock’s Outset Medical OM Stock Holding History

BlackRock’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.81M Sell
418,211
-845,008
-67% -$3.7M ﹤0.01% 4184
2026
Q1 		$4.85M Sell
1,263,219
-26,099
-2% -$107K ﹤0.01% 3844
2025
Q4 		$4.78M Buy
1,289,318
+40,362
+3% +$346K ﹤0.01% 3853
2025
Q3 		$17.6M Buy
1,248,956
+265,065
+27% +$4.13M ﹤0.01% 3156
2025
Q2 		$18.9M Buy
983,891
+917,973
+1,393% +$14.3M ﹤0.01% 3066
2025
Q1 		$729K Buy
65,918
+3,361
+5% +$40.1K ﹤0.01% 4285
2024
Q4 		$1.04M Buy
62,557
+1,838
+3% +$22.9K ﹤0.01% 4209
2024
Q3 		$617K Buy
60,719
+2,022
+3% +$60.1K ﹤0.01% 4281
2024
Q2 		$3.39M Sell
58,697
-159,053
-73% -$7.79M ﹤0.01% 3817
2024
Q1 		$7.25M Sell
217,750
-35,278
-14% -$1.79M ﹤0.01% 3520
2023
Q4 		$20.5M Buy
253,028
+5,125
+2% +$417K ﹤0.01% 3004
2023
Q3 		$40.5M Buy
247,903
+12,293
+5% +$2.9M ﹤0.01% 2524
2023
Q2 		$77.3M Buy
235,610
+6,582
+3% +$2.01M ﹤0.01% 2218
2023
Q1 		$63.2M Sell
229,028
-4,313
-2% -$1.58M ﹤0.01% 2292
2022
Q4 		$90.4M Buy
233,341
+12,764
+6% +$3.6M ﹤0.01% 2059
2022
Q3 		$52.7M Buy
220,577
+5,033
+2% +$1.35M ﹤0.01% 2403
2022
Q2 		$48M Sell
215,544
-58,783
-21% -$25.3M ﹤0.01% 2526
2022
Q1 		$187M Sell
274,327
-27,624
-9% -$16.6M 0.01% 1723
2021
Q4 		$209M Sell
301,951
-20,088
-6% -$14.9M 0.01% 1708
2021
Q3 		$239M Buy
322,039
+66,621
+26% +$45.4M 0.01% 1575
2021
Q2 		$191M Buy
255,418
+193,740
+314% +$148M 0.01% 1798
2021
Q1 		$50.3M Buy
61,678
+11,640
+23% +$8.98M ﹤0.01% 2606
2020
Q4 		$42.7M Buy
50,038
+48,449
+3,049% +$37.3M ﹤0.01% 2573
2020
Q3 		$1.19M Buy
+1,589
New +$1.3M ﹤0.01% 4066

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

BlackRock's OM Position: Q2 2026 in Review

BlackRock reduced its Outset Medical (OM) stake by 67% in Q2 2026, selling an estimated $3.7M and leaving 418,211 shares worth $1.81M. The position accounts for ﹤0.01% of the portfolio, ranked #4184.

BlackRock first reported a position in OM in Q3 2020 and has held it in 24 quarters since. The position peaked at $239M in Q3 2021. 93 funds tracked by Wall St. Rank hold OM as of Q2 2026.

  • BlackRock held 418,211 shares of Outset Medical worth $1.81M as of Q2 2026.
  • BlackRock sold 845,008 Outset Medical shares in Q2 2026, an estimated $3.7M.
  • Outset Medical made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4184 holding.
  • BlackRock first reported a position in Outset Medical in Q3 2020 and has held it in 24 quarters since.
  • BlackRock's Outset Medical position peaked at $239M in Q3 2021.
  • 93 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.